The Indian Pharmacopoeia (IP) has been recognised formally by the National Department of Regulation of Medicines and Health Products of the Ministry of Public Health of Islamic Republic of Afghanistan. It will also be used based on the requirement as reputable pharmacopoeia in the laboratory of medicines and health products quality. With this, a new beginning has been made and Afghanistan has become the first country to recognize IP pursuant to the efforts of the Department of Commerce and Ministry of Health and Family Welfare.
IP is an officially recognized book of standards as per the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder. The IP specifies the standards of drugs manufactured and marketed in India in terms of their identity, purity and strength.
The quality, efficacy and safety of the medicines are important from a healthcare perspective. In order to ensure the quality of medicinal products, the legal and scientific standards are provided by the Indian Pharmacopoeia Commission (IPC) in the form of Indian Pharmacopoeia (IP). As per, the Second Schedule of the Drugs and Cosmetics Act, IP is designated as the official book of standards for drugs imported and/or manufactured for sale, stock or exhibition for sale or distribution in India.
The IP Commission’s mission is to promote public and animal health in India by bringing out authoritative and officially accepted standards for quality of drugs including active pharmaceutical ingredients, excipients and dosage forms, used by health professionals, patients and consumers. This is achieved by developing the standards for medicines and supporting their implementation. In addition, IPC also develops IP Reference Substances (IPRS) that act as a fingerprint for identification of an article under test and its purity as prescribed in the IP monographs. Standards prescribed in the IP are authoritative in nature and are enforced by the regulatory authorities for quality control of medicines in India.